Connolly Dean, Davies Emma, Lynskey Michael, Barratt Monica J, Maier Larissa, Ferris Jason, Winstock Adam, Gilchrist Gail
Addictions Sciences Building, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Newham University Hospital, Barts Health NHS Trust, London, UK.
Faculty of Health and Life Sciences, Oxford Brookes University, UK.
J Subst Abuse Treat. 2020 May;112:86-91. doi: 10.1016/j.jsat.2020.03.001. Epub 2020 Mar 3.
Transgender (trans) people experience stressors related to their minority status which have been associated with increased rates of psychoactive substance use and related harm. Despite this, there is a paucity of evidence relating to the treatment needs of trans people who use psychoactive substances, beyond a small body of literature describing a culture of transphobic hostility in general substance misuse services. This paper aims to describe and compare psychoactive substance misuse help-seeking among trans and cisgender (cis) participants from a large multi-national cross-sectional survey.
Over 180,000 participants, recruited from the world's largest annual survey of drug use - the Global Drug Survey - during 2018 and 2019, reported use of a range of psychoactive substances in the preceding 12 months. Five gender groups (118,157 cis men, 64,319 cis women, 369 trans men, 353 trans women and 1857 non-binary people) were compared on items relating to the desire to use less psychoactive substances and the need to seek help to achieve this.
Trans respondents (n = 1710) to GDS 2018 were significantly more likely to report use of illicit substances (OR = 1.66-2.93) and dependence on cannabis (OR = 2.39) and alcohol (OR = 3.28). In the combined GDS 2018 and 2019 dataset, there were no significant differences between trans (n = 2579) and cis (n = 182,476) participants on the desire to reduce substance use. However, among those who did report wanting to use less, trans participants were more likely to want help to achieve this.
Trans respondents reported a greater need for help with reducing substance use than cis respondents. Given the deficit of specialist services for psychoactive substance users who are trans, there is a need for a more thorough understanding of the barriers and facilitators to their engagement in general substance misuse services. In the interim, substance misuse service providers require education about gender minority status to help meet the needs of trans clients.
跨性别者面临与他们的少数群体身份相关的压力源,这些压力源与精神活性物质使用增加及相关危害有关。尽管如此,除了一小部分描述一般药物滥用服务中存在恐跨敌意文化的文献外,关于使用精神活性物质的跨性别者的治疗需求的证据很少。本文旨在通过一项大型跨国横断面调查,描述和比较跨性别参与者和顺性别参与者在精神活性物质滥用方面寻求帮助的情况。
在2018年和2019年从全球最大的年度药物使用调查——全球药物调查中招募了超过180,000名参与者,他们报告了在过去12个月内使用的一系列精神活性物质。比较了五个性别组(118,157名顺性别男性、64,319名顺性别女性、369名跨性别男性、353名跨性别女性和1857名非二元性别者)在与减少精神活性物质使用意愿以及为此寻求帮助的必要性相关的项目上的情况。
2018年全球药物调查的跨性别受访者(n = 1710)报告使用非法物质(OR = 1.66 - 2.93)、对大麻(OR = 2.39)和酒精(OR = 3.28)产生依赖的可能性显著更高。在2018年和2019年全球药物调查的合并数据集中,跨性别参与者(n = 2,